Low-dose parenteral busulfan provides an extended window for the infusion of hematopoietic stem cells in murine hosts

Nonmyeloablative parenteral busulfan produced transient myelosuppressive effects, clinically relevant levels of engraftment, and an extended time window for HSC infusion in murine hosts.